Analysis of risk factors for early death in patients with acute promyelocytic leukaemia treated with arsenic trioxide. Wang Y, Hou W, Li H, Tian X, et al. Ann Hematol 2022;101:1039-1047.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Wang Y, Hou W, Li H, Tian X, et al. Analysis of risk factors for early death in patients with acute promyelocytic leukaemia treated with arsenic trioxide. Ann Hematol 2022;101:1039-1047.
PMID: 35174404